Ubs Asset Management Americas Inc Vbi Vaccines Inc Transaction History

Ubs Asset Management Americas Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.73 - $23.4 $29,565 - $947,700	-40,500 Reduced 26.11%	114,610 $0
Q2 2021 Aug 16, 2021	BUY	$2.61 - $4.17 $6,673 - $10,662	2,557 Added 1.68%	155,110 $519,000
Q1 2021 May 14, 2021	SELL	$2.91 - $4.32 $582 - $864	-200 Reduced 0.13%	152,553 $474,000
Q4 2020 Mar 01, 2021	BUY	$2.15 - $3.5 $328,418 - $534,635	152,753 New	152,753 $420,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

Stay updated on Ubs Asset Management Americas Inc with notifications on news.